Companies: 10,795·Total market cap: $144.5T

HUTCHMED (China) Limited

HUTCHMED (China) Limited

HCMNASDAQHealthcare● Active

$10.85

$-0.03(-0.23%)

Market Cap$1.9B

P/E Ratio—

52W High$19.5

52W Low$10.8113

Avg Volume39K

Open$10.90

Beta0.37

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

HUTCHMED (China) Limited（HCM）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HCM · 截至 Jun 8, 2026

关键指标

EPS (TTM)$2.77Earnings history

PE Ratio (TTM)3.9×PE Ratio deep dive

Revenue (TTM)$602.2MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding171.7MShares outstanding history

Next EarningsAug 3, 2026Est.Earnings history

探索 HUTCHMED (China) Limited 数据

分析师预测$14 · Buy

股息不分红

营收$550.0M-12.73%

盈利EPS $2.65+1104.55%

财务快照

FY 2025Revenue$550.0M▼ 12.73% YoY

202320242025

FY 2025Net Income$458.1M▲ +1114.23% YoY

202320242025

FY 2025EPS$2.65▲ +1104.55% YoY

202320242025

TTM:Revenue: $602.2MNet Income: $466.9MEPS: $2.77View income statement →

分析师评级与目标价

Buy10 位分析师

Strong Buy

0

Buy

8

Hold

1

Sell

1

Strong Sell

0

12-Month Price Target

$13.60Low

$10.85Current

$13.60Avg Target上涨空间 25.40%

$13.60High

合计: 10 · 买入占比: 80.0%

根据过去 3 个月内 10 位华尔街分析师，HCM 共识评级为 Buy，12 个月平均目标价 $13.60 （较现价 $10.85 上涨空间 25.40%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

HUTCHMED (China) Limited

$10.85-0.23%$1.9B #2

Adaptive Biotechnologies Corporation

$16.80-0.66%$2.7B #3

Bausch Health Companies Inc.

$5.24-3.45%$2.0B #4

Cidara Therapeutics, Inc.

$221.38+0.00%$5.6B #5

Catalyst Pharmaceuticals, Inc.

$31.28+0.03%$3.8B #6

IDEAYA Biosciences, Inc.

$31.03+9.86%$2.7B

股票表现

1D-0.23%

1W-5.86%

1M-17.40%

3M-21.70%

YTD-18.64%

1Y-32.05%

5Y-64.44%

关于 HUTCHMED (China) Limited

CEOChig Fung Cheng

IPO DateMar 16, 2016

Employees1,811

CountryHK

Websitehutch-med.com

HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncolog…

Drug Manufacturers - Specialty & Generic HealthcareNASDAQADRHK

关于股票概览与关键数据

HUTCHMED (China) Limited（HCM）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Mar 16, 2016 在 NASDAQ 上市。截至最近交易日，HCM 股价为 $10.85，市值约为 $1.9B。过去12个月累计回报 -32.05%，年初至今回报 -18.64%。

根据 10 位华尔街分析师，HUTCHMED (China) Limited 股票共识评级为Buy，12个月平均目标价为 $13.60。2025 财年 HUTCHMED (China) Limited 营收 $550.0M，净利润 $458.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，HUTCHMED (China) Limited（HCM）股价为 $10.85，在 NASDAQ 上市，52周区间为 $10.81 – $19.50。

HCM 最新股价HCM quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议